Jörgen Bergman - UTU Research Portal

Jörgen Bergman

Turku PET Centre (Independent units)

jorber@utu.fi

2 of 2

Visualization and quantification of neurokinin-1 (NK1) receptors in the human brain (2005) Hietala J, Nyman MJ, Eskola O, Laakso A, Grönroos T, Oikonen V, Bergman J, Haaparanta M, Forsback S, Marjamäki P, Lehikoinen P, Goldberg M, Burns D, Hamill T, Eng WS, Coimbra A, Hargreaves R, Solin O
Defective liver disposal of free fatty acids in patients with impaired glucose tolerance (2004) Iozzo P1, Turpeinen AK, Takala T, Oikonen V, Bergman J, Grönroos T, Ferrannini E, Nuutila P, Knuuti J
Effect of training status on regional disposal of circulating free fatty acids in the liver and skeletal muscle during physiological hyperinsulinemia (2004) Iozzo P, Takala T, Oikonen V, Bergman J, Grönroos T, Ferrannini E, Nuutila P, Knuuti J
Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: ([18F]SPA-RQ) (2004) Solin O1, Eskola O, Hamill TG, Bergman J, Lehikoinen P, Grönroos T, Forsback S, Haaparanta M, Viljanen T, Ryan C, Gibson R, Kieczykowski G, Hietala J, Hargreaves R, Burns HD
Uptake of 6-[18F]Fluoro-L-Dopa and [18F]CFT Reflect Nigral Neuronal Loss in a Rat Model of Parkinson's Disease (2004)
- Synapse
Forsback S., Niemi R., Marjamäki P., Eskola O., Bergman J., Grönroos T., Haaparanta M., Haapalinna A., Rinne J., Solin O.
2-[(18)F]fluoro-2-deoxy-D-glucose combined with microdialysis can be used for the comparison of tissue glucose metabolism in obese and lean rats (2002)
- Diabetes, Obesity and Metabolism
Virtanen KA, Haaparanta M, Grönroos T, Bergman J, Solin O, Rouru J, Nuutila P, Huupponen R
2-[18F]fluoro-2-deoxy-D-glucose combined with microdialysis can be used for the comparison of tissue glucose metabolism in obese and lean rats (2002)
- Diabetes, Obesity and Metabolism
Virtanen K.A., Haaparanta M., Grönroos T., Bergman J., Solin O., Rouru J., Nuutila P., Huupponen R.
Role of the dopaminergic system in chronic pain – a fluorodopa-PET study. (2001)
- PAIN
Jääskeläinen SK, Rinne JO, Forssell H, Tenovuo O, Kaasinen V, Sonninen P, Bergman J.
An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome (2000)
- Neurology
Ruottinen HM, Partinen M, Hublin C, Bergman J, Haaparanta M, Solin O, Rinne JO
Cognitive impairment and the brain dopaminergic system in Parkinson disease - [F-18]fluorodopa positron emission tomographic study (2000)
- Archives of Neurology -Chigago-
Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M, Solin O
Prediction of detached personality in healthy subjects by low dopamine transporter binding (2000)
- American Journal of Psychiatry
Laakso A, Vilkman H, Kajander J, Bergman J, Haaparanta M, Solin O, Hietala J
Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT (2000)
- Annals of Neurology
Nurmi E, Ruottinen HM, Kaasinen V, Bergman J, Haaparanta M, Solin O, Rinne JO
Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography (2000)
- American Journal of Psychiatry
Laakso A, Vilkman H, Alakare B, Haaparanta M, Bergman J, Solin O, Peurasaari J, Rakkolainen V, Syvalahti E, Hietala J
Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease (1999)
- Journal of Neurology, Neurosurgery and Psychiatry
Rinne JO, Ruottinen H, Bergman J, Haaparanta M, Sonninen P, Solin O
Cerebral metabolic rate for glucose after neonatal hypoglycaemia (1997)
- Early Human Development
Kinnala A, Nuutila P, Ruotsalainen U, Teräs M, Bergman J, Haaparanta M, Solin O, Korvenranta H, Aärimaa T, Wegelius U, Kero P, Suhonen-Polvi H
Cerebral metabolic rate for glucose after neonatal hypoglycaemia (1997)
- Early Human Development
Kinnala A, Nuutila P, Ruotsalainen U, Teräs M, Bergman J, Haaparanta M, Solin O, Korvenranta H, Aärimaa T, Wegelius U, Kero P, Suhonen-Polvi H
Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study (1996)
- Archives of Disease in Childhood Fetal and Neonatal Edition
Kinnala A, Suhonen-Polvi H, Aärimaa T, Kero P, Korvenranta H, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Nuutila P, Wegelius U
Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study (1996)
- Archives of Disease in Childhood Fetal and Neonatal Edition
Kinnala A, Suhonen-Polvi H, Aärimaa T, Kero P, Korvenranta H, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Nuutila P, Wegelius U